AU Stock MarketDetailed Quotes

Neuren Pharmaceuticals Ltd (NEU)

Watchlist
  • 12.790
  • -0.060-0.47%
20min DelayMarket Closed May 15 16:00 AET
1.62BMarket Cap54.89P/E (Static)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Neuren Pharmaceuticals Ltd (NEU) Balance Sheet

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 30, 2025
(Q4)Dec 30, 2025
(FY)Dec 30, 2024
(Q4)Dec 30, 2024
(FY)Dec 30, 2023
(Q4)Dec 30, 2023
(FY)Dec 30, 2022
(Q4)Dec 30, 2022
(FY)Dec 30, 2021
(Q4)Dec 30, 2021
Assets
Current assets
Cash, cash equivalents and short term investments
33.24%296.12M
33.24%296.12M
-2.76%222.24M
-2.76%222.24M
468.79%228.54M
468.79%228.54M
9.24%40.18M
9.24%40.18M
52.07%36.78M
52.07%36.78M
-Cash and cash equivalents
34.06%4.23M
34.06%4.23M
-81.55%3.15M
-81.55%3.15M
-57.46%17.09M
-57.46%17.09M
9.24%40.18M
9.24%40.18M
52.07%36.78M
52.07%36.78M
-Short term investments
33.23%291.9M
33.23%291.9M
3.62%219.09M
3.62%219.09M
--211.45M
--211.45M
----
----
----
----
Receivables
-98.85%1.81M
-98.85%1.81M
993.33%157.57M
993.33%157.57M
1,223.42%14.41M
1,223.42%14.41M
-23.53%1.09M
-23.53%1.09M
88.61%1.42M
88.61%1.42M
-Accounts receivable
-99.71%450K
-99.71%450K
--155.15M
--155.15M
----
----
----
----
--7K
--7K
-Other receivables
-43.63%1.36M
-43.63%1.36M
-83.24%2.42M
-83.24%2.42M
1,223.42%14.41M
1,223.42%14.41M
-23.15%1.09M
-23.15%1.09M
87.68%1.42M
87.68%1.42M
Prepaid assets
2,310.08%9.57M
2,310.08%9.57M
-90.56%397K
-90.56%397K
112.70%4.21M
112.70%4.21M
7.62%1.98M
7.62%1.98M
--1.84M
--1.84M
Current deferred assets
--5.81M
--5.81M
----
----
----
----
----
----
----
----
Hedging assets-current
----
----
--1.36M
--1.36M
----
----
----
----
----
----
Other current assets
6.58%18.92M
6.58%18.92M
--17.76M
--17.76M
----
----
----
----
----
----
Total current assets
-16.80%332.23M
-16.80%332.23M
61.57%399.33M
61.57%399.33M
471.51%247.16M
471.51%247.16M
8.00%43.25M
8.00%43.25M
60.54%40.04M
60.54%40.04M
Non current assets
Net PPE
45.16%45K
45.16%45K
-27.91%31K
-27.91%31K
104.76%43K
104.76%43K
75.00%21K
75.00%21K
20.00%12K
20.00%12K
-Gross PPE
45.16%45K
45.16%45K
-27.91%31K
-27.91%31K
104.76%43K
104.76%43K
75.00%21K
75.00%21K
20.00%12K
20.00%12K
Non current deferred assets
2.25%10.58M
2.25%10.58M
1,242.15%10.35M
1,242.15%10.35M
--771K
--771K
----
----
----
----
Total non current assets
2.38%10.63M
2.38%10.63M
1,175.06%10.38M
1,175.06%10.38M
3,776.19%814K
3,776.19%814K
75.00%21K
75.00%21K
20.00%12K
20.00%12K
Total assets
-16.32%342.86M
-16.32%342.86M
65.22%409.71M
65.22%409.71M
473.12%247.97M
473.12%247.97M
8.02%43.27M
8.02%43.27M
60.53%40.06M
60.53%40.06M
Liabilities
Current liabilities
Payables
-17.03%2.4M
-17.03%2.4M
-15.30%2.9M
-15.30%2.9M
249.49%3.42M
249.49%3.42M
21.79%978K
21.79%978K
6.64%803K
6.64%803K
-accounts payable
-39.48%877K
-39.48%877K
114.67%1.45M
114.67%1.45M
161.63%675K
161.63%675K
5.31%258K
5.31%258K
46.71%245K
46.71%245K
-Other payable
5.46%1.53M
5.46%1.53M
-47.28%1.45M
-47.28%1.45M
280.97%2.74M
280.97%2.74M
29.03%720K
29.03%720K
-4.78%558K
-4.78%558K
Current provisions
--1.94M
--1.94M
----
----
218.00%2.23M
218.00%2.23M
--700K
--700K
----
----
Current deferred liabilities
----
----
15.48%42.87M
15.48%42.87M
--37.12M
--37.12M
----
----
----
----
Current liabilities
-90.52%4.34M
-90.52%4.34M
7.01%45.76M
7.01%45.76M
2,448.45%42.76M
2,448.45%42.76M
108.97%1.68M
108.97%1.68M
6.64%803K
6.64%803K
Non current liabilities
Employee benefits
65.85%68K
65.85%68K
--41K
--41K
----
----
----
----
----
----
Total non current liabilities
65.85%68K
65.85%68K
--41K
--41K
--0
--0
--0
--0
--0
--0
Total liabilities
-90.38%4.41M
-90.38%4.41M
7.11%45.8M
7.11%45.8M
2,448.45%42.76M
2,448.45%42.76M
108.97%1.68M
108.97%1.68M
6.64%803K
6.64%803K
Shareholders'equity
Share capital
-18.35%134.94M
-18.35%134.94M
-4.54%165.27M
-4.54%165.27M
3.21%173.13M
3.21%173.13M
0.10%167.74M
0.10%167.74M
15.12%167.58M
15.12%167.58M
-common stock
-18.35%134.94M
-18.35%134.94M
-4.54%165.27M
-4.54%165.27M
3.21%173.13M
3.21%173.13M
0.10%167.74M
0.10%167.74M
15.12%167.58M
15.12%167.58M
Retained earnings
16.87%210.87M
16.87%210.87M
370.02%180.43M
370.02%180.43M
132.34%38.39M
132.34%38.39M
0.15%-118.69M
0.15%-118.69M
-7.02%-118.88M
-7.02%-118.88M
Gains losses not affecting retained earnings
-140.42%-7.36M
-140.42%-7.36M
388.57%18.2M
388.57%18.2M
15.42%-6.31M
15.42%-6.31M
21.06%-7.46M
21.06%-7.46M
8.13%-9.45M
8.13%-9.45M
Total stockholders'equity
-6.99%338.45M
-6.99%338.45M
77.34%363.9M
77.34%363.9M
393.42%205.21M
393.42%205.21M
5.95%41.59M
5.95%41.59M
62.20%39.25M
62.20%39.25M
Total equity
-6.99%338.45M
-6.99%338.45M
77.34%363.9M
77.34%363.9M
393.42%205.21M
393.42%205.21M
5.95%41.59M
5.95%41.59M
62.20%39.25M
62.20%39.25M
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(FY)Dec 30, 2025(Q4)Dec 30, 2025(FY)Dec 30, 2024(Q4)Dec 30, 2024(FY)Dec 30, 2023(Q4)Dec 30, 2023(FY)Dec 30, 2022(Q4)Dec 30, 2022(FY)Dec 30, 2021(Q4)Dec 30, 2021
Assets
Current assets
Cash, cash equivalents and short term investments 33.24%296.12M33.24%296.12M-2.76%222.24M-2.76%222.24M468.79%228.54M468.79%228.54M9.24%40.18M9.24%40.18M52.07%36.78M52.07%36.78M
-Cash and cash equivalents 34.06%4.23M34.06%4.23M-81.55%3.15M-81.55%3.15M-57.46%17.09M-57.46%17.09M9.24%40.18M9.24%40.18M52.07%36.78M52.07%36.78M
-Short term investments 33.23%291.9M33.23%291.9M3.62%219.09M3.62%219.09M--211.45M--211.45M----------------
Receivables -98.85%1.81M-98.85%1.81M993.33%157.57M993.33%157.57M1,223.42%14.41M1,223.42%14.41M-23.53%1.09M-23.53%1.09M88.61%1.42M88.61%1.42M
-Accounts receivable -99.71%450K-99.71%450K--155.15M--155.15M------------------7K--7K
-Other receivables -43.63%1.36M-43.63%1.36M-83.24%2.42M-83.24%2.42M1,223.42%14.41M1,223.42%14.41M-23.15%1.09M-23.15%1.09M87.68%1.42M87.68%1.42M
Prepaid assets 2,310.08%9.57M2,310.08%9.57M-90.56%397K-90.56%397K112.70%4.21M112.70%4.21M7.62%1.98M7.62%1.98M--1.84M--1.84M
Current deferred assets --5.81M--5.81M--------------------------------
Hedging assets-current ----------1.36M--1.36M------------------------
Other current assets 6.58%18.92M6.58%18.92M--17.76M--17.76M------------------------
Total current assets -16.80%332.23M-16.80%332.23M61.57%399.33M61.57%399.33M471.51%247.16M471.51%247.16M8.00%43.25M8.00%43.25M60.54%40.04M60.54%40.04M
Non current assets
Net PPE 45.16%45K45.16%45K-27.91%31K-27.91%31K104.76%43K104.76%43K75.00%21K75.00%21K20.00%12K20.00%12K
-Gross PPE 45.16%45K45.16%45K-27.91%31K-27.91%31K104.76%43K104.76%43K75.00%21K75.00%21K20.00%12K20.00%12K
Non current deferred assets 2.25%10.58M2.25%10.58M1,242.15%10.35M1,242.15%10.35M--771K--771K----------------
Total non current assets 2.38%10.63M2.38%10.63M1,175.06%10.38M1,175.06%10.38M3,776.19%814K3,776.19%814K75.00%21K75.00%21K20.00%12K20.00%12K
Total assets -16.32%342.86M-16.32%342.86M65.22%409.71M65.22%409.71M473.12%247.97M473.12%247.97M8.02%43.27M8.02%43.27M60.53%40.06M60.53%40.06M
Liabilities
Current liabilities
Payables -17.03%2.4M-17.03%2.4M-15.30%2.9M-15.30%2.9M249.49%3.42M249.49%3.42M21.79%978K21.79%978K6.64%803K6.64%803K
-accounts payable -39.48%877K-39.48%877K114.67%1.45M114.67%1.45M161.63%675K161.63%675K5.31%258K5.31%258K46.71%245K46.71%245K
-Other payable 5.46%1.53M5.46%1.53M-47.28%1.45M-47.28%1.45M280.97%2.74M280.97%2.74M29.03%720K29.03%720K-4.78%558K-4.78%558K
Current provisions --1.94M--1.94M--------218.00%2.23M218.00%2.23M--700K--700K--------
Current deferred liabilities --------15.48%42.87M15.48%42.87M--37.12M--37.12M----------------
Current liabilities -90.52%4.34M-90.52%4.34M7.01%45.76M7.01%45.76M2,448.45%42.76M2,448.45%42.76M108.97%1.68M108.97%1.68M6.64%803K6.64%803K
Non current liabilities
Employee benefits 65.85%68K65.85%68K--41K--41K------------------------
Total non current liabilities 65.85%68K65.85%68K--41K--41K--0--0--0--0--0--0
Total liabilities -90.38%4.41M-90.38%4.41M7.11%45.8M7.11%45.8M2,448.45%42.76M2,448.45%42.76M108.97%1.68M108.97%1.68M6.64%803K6.64%803K
Shareholders'equity
Share capital -18.35%134.94M-18.35%134.94M-4.54%165.27M-4.54%165.27M3.21%173.13M3.21%173.13M0.10%167.74M0.10%167.74M15.12%167.58M15.12%167.58M
-common stock -18.35%134.94M-18.35%134.94M-4.54%165.27M-4.54%165.27M3.21%173.13M3.21%173.13M0.10%167.74M0.10%167.74M15.12%167.58M15.12%167.58M
Retained earnings 16.87%210.87M16.87%210.87M370.02%180.43M370.02%180.43M132.34%38.39M132.34%38.39M0.15%-118.69M0.15%-118.69M-7.02%-118.88M-7.02%-118.88M
Gains losses not affecting retained earnings -140.42%-7.36M-140.42%-7.36M388.57%18.2M388.57%18.2M15.42%-6.31M15.42%-6.31M21.06%-7.46M21.06%-7.46M8.13%-9.45M8.13%-9.45M
Total stockholders'equity -6.99%338.45M-6.99%338.45M77.34%363.9M77.34%363.9M393.42%205.21M393.42%205.21M5.95%41.59M5.95%41.59M62.20%39.25M62.20%39.25M
Total equity -6.99%338.45M-6.99%338.45M77.34%363.9M77.34%363.9M393.42%205.21M393.42%205.21M5.95%41.59M5.95%41.59M62.20%39.25M62.20%39.25M
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +2.64%
Sample Name
Sample Code
 -0.13%
Sample Name
Sample Code
 -1.05%
4
SHANGHAI PECHEM
00338
-1.56%
5
SINOPEC CORP
00386
-2.39%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +41.26%
Sample Name
Sample Code
 +31.66%
Sample Name
Sample Code
 +26.25%
4
Digital China Group
000034
+15.29%
5
Loongson Technology Corporation
688047
+12.74%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -